TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Recipharm AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 595,436 | 247,874 | 11,068,600 |
Financial expenses | 3,428,349 | 1,637,762 | 537,200 |
Earnings before taxes | -21,087 | 78,809 | 498,400 |
EBITDA | -176,402 | -248,631 | 1,950,700 |
Total assets | 29,509,387 | 17,368,210 | 21,637,800 |
Current assets | 3,974,858 | 2,496,485 | 6,055,600 |
Current liabilities | 2,114,465 | 1,663,025 | 3,362,100 |
Equity capital | 17,984,299 | 7,066,773 | 7,354,700 |
- share capital | 50,558 | 50,558 | 33,900 |
Employees (average) | 67 | 64 | 7,857 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 60.9% | 40.7% | 34.0% |
Turnover per employee | 8,887 | 3,873 | 1,409 |
Profit as a percentage of turnover | -3.5% | 31.8% | 4.5% |
Return on assets (ROA) | 11.5% | 9.9% | 4.8% |
Current ratio | 188.0% | 150.1% | 180.1% |
Return on equity (ROE) | -0.1% | 1.1% | 6.8% |
Change turnover | 347,562 | -10,820,726 | 3,611,500 |
Change turnover % | 140% | 48% | |
Chg. No. of employees | 3 | -7,793 | 2,541 |
Chg. No. of employees % | 5% | 48% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.